These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 139317)

  • 21. Effect of ethanolamine-O-sulphate on regional GABA metabolism in the mouse brain.
    Leach MJ; Walker JM
    Biochem Pharmacol; 1977 Sep; 26(17):1569-72. PubMed ID: 901577
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of chronic treatment with the GABA transaminase inhibitors gamma-vinyl GABA and ethanolamine O-sulphate on the in vitro GABA release from rat hippocampus.
    Qume M; Fowler LJ
    Br J Pharmacol; 1997 Oct; 122(3):539-45. PubMed ID: 9351512
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute anticonvulsant activity of structural analogues of valproic acid and changes in brain GABA and aspartate content.
    Chapman AG; Meldrum BS; Mendes E
    Life Sci; 1983 Apr; 32(17):2023-31. PubMed ID: 6403794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anticonvulsant activity of intracerebroventricularly administered valproate and valproate analogues. A dose-dependent correlation with changes in brain aspartate and GABA levels in DBA/2 mice.
    Chapman AG; Croucher MJ; Meldrum BS
    Biochem Pharmacol; 1984 May; 33(9):1459-63. PubMed ID: 6428419
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of analogues of valproic acid on seizures induced by pentylenetetrazol and GABA content in brain of mice.
    Keane PE; Simiand J; Mendes E; Santucci V; Morre M
    Neuropharmacology; 1983 Jul; 22(7):875-9. PubMed ID: 6413882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential effects of gamma-aminobutyric acid (GABA)-elevating agents on the neuroleptic-induced activation of striatal tyrosine-hydroxylase: evidence that di-n-propylacetate augments GABAergic neurotransmission.
    Casu M; Gale K
    J Pharmacol Exp Ther; 1981 Apr; 217(1):177-80. PubMed ID: 6110774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro changes in gamma-aminobutyric acid output from the cerebral cortex induced by inhibitors of gamma-aminobutyric acid uptake and metabolism.
    Moroni F; Mulas A; Moneti G; Pepeu G
    J Neurochem; 1982 Aug; 39(2):582-4. PubMed ID: 7086436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic administration of the GABA-transaminase inhibitor ethanolamine O-sulphate leads to up-regulation of GABA binding sites.
    Sykes C; Prestwich S; Horton R
    Biochem Pharmacol; 1984 Feb; 33(3):387-93. PubMed ID: 6322803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Time course of the increase in GABA level in different mice brain regions following N-dipropylacetate treatment.
    Simler S; Gensburger C; Ciesielski L; Mandel P
    Commun Psychopharmacol; 1978; 2(2):123-30. PubMed ID: 352606
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of valproate on brain GABA: comparison with various medium chain fatty acids.
    Keane PE; Morre M
    Pharmacol Res Commun; 1985 Jun; 17(6):547-55. PubMed ID: 3927325
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of sodium valproate and ethanolamine-o-sulphate on GABA metabolism in vivo [proceedings].
    Taberner PV
    Br J Pharmacol; 1979 Nov; 67(3):441P. PubMed ID: 387149
    [No Abstract]   [Full Text] [Related]  

  • 32. Circling behaviour in the rat following unilateral injections of p-chlorophenylalanine and ethanolamine-O-sulphate into the substantia nigra.
    Tanner T
    J Pharm Pharmacol; 1978 Mar; 30(3):158-61. PubMed ID: 24688
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biochemical effects in man and rat of three drugs which can increase brain GABA content.
    Perry TL; Hansen S
    J Neurochem; 1978 Apr; 30(4):679-84. PubMed ID: 148494
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of sodium n-dipropylacetate on audiogenic seizures and brain -aminobutyric acid level.
    Simler S; Ciesielski L; Maitre M; Randrianarisoa H; Mandel P
    Biochem Pharmacol; 1973 Jul; 22(14):1701-8. PubMed ID: 4351900
    [No Abstract]   [Full Text] [Related]  

  • 35. Adaptation of the GABAA-receptor complex in rat brain during chronic elevation of GABA by ethanolamine O-sulphate.
    Lindgren S; Simmonds MA
    Br J Pharmacol; 1987 Jul; 91(3):617-25. PubMed ID: 3038247
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regional changes in the concentrations of cerebral monoamines and their metabolites after ethanolamine-O-sulphate induced elevation of brain gamma-aminobutyric acid concentrations.
    Pycock C; Horton R
    Biochem Pharmacol; 1978; 27(14):1827-30. PubMed ID: 30457
    [No Abstract]   [Full Text] [Related]  

  • 37. Suppression of GABA-induced abstinence behaviour in naive rats by morphine and bicuculline.
    de Boer T; Metselaar HJ; Bruinvels J
    Life Sci; 1977 Mar; 20(6):933-41. PubMed ID: 191711
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of inhibitors of GABA-transaminase on hole-board exploration and on temperature. Relation with effects on quasi-morphine abstinence behaviour induced by sodium dipropylacetate.
    van der Laan JW; Weick G; van Bleek G
    Biochem Pharmacol; 1985 Nov; 34(21):3789-94. PubMed ID: 3933514
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Audiogenic seizure protection by elevated brain GABA concentration in mice: effects of gamma-acetylenic gaba and gamma-vinyl GABA, two irreversible GABA-T inhibitors.
    Schechter PJ; Tranier Y; Jung MJ; Böhlen P
    Eur J Pharmacol; 1977 Oct; 45(4):319-28. PubMed ID: 923642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The level of GABA in the brain and locomotor behavior.
    Grimm V; Gottesfeld Z; Wassermann I; Samuel D
    Pharmacol Biochem Behav; 1975; 3(4):573-8. PubMed ID: 1103159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.